Status:
COMPLETED
Neuromuscular Electrical Stimulation and Motor Control
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
National Taiwan University
Conditions:
Instability; Back
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Phase I, this study aims to:- 1. Establish intra- and inter-rater reliability and minimal detectable change of ultrasound imaging measurement 2. Determine appropriate mode and dose for neuromuscular ...
Detailed Description
Phase I: Preliminary study Subjects aged between 20 and 40 with and without history of low back pain will be recruited. Subjects who are interested in participation will undergo a screening process us...
Eligibility Criteria
Inclusion
- The inclusion criteria for individuals without impaired LPC
- Between the ages of 20 and 40
- No history of LBP that interferes with activities of daily living and/or required treatment
- No aberrant movement pattern during active forward bend test
- Passive straight leg raising test (SLR) less than 91 degrees
- The inclusion criteria for individuals with impaired LPC
- Between the ages of 20 and 40
- A recurrent pattern of LBP at least two episodes that interfered with activities of daily living and/or required treatment
- Presenting aberrant movement pattern during active forward bend test
- Passive straight leg raising test (SLR) greater than 91 degrees
Exclusion
- History of seizure for either the subject or any family member
- Implanted pacemaker
- Clinical signs of systemic disease
- Definitive neurologic signs including pain, weakness or numbness in the lower extremity
- Previous spinal surgery
- Diagnosed osteoporosis, severe spinal stenosis, and/or inflammatory joint disease
- Any lower extremity condition that would potentially alter trunk movement
- Vestibular dysfunction
- Extreme psychosocial involvement
- Body mass index (BMI) greater than 30 kg/m2
- Active treatment of another medical illness that would preclude participation in any aspect of the study
- Menstruation or pregnancy (for female subject)
- Diagnosed herniated nucleus pulposus (HNP)
- Pain medication usage (e.g., NSAID)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03786627
Start Date
April 1 2019
End Date
December 31 2022
Last Update
March 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy, Mahidol University
Salaya, Changwat Nakhon Pathom, Thailand, 73170